Moreover, the primary effusion lymphoma usually coexisting with CD38 expression and HIV infection can be effectively treated with daratumumab, with a clinical response confirmed by imaging and a reduction in the viral load [158]. The gene discussed is CD38; the disease is HIV infectious disease.